CN

Hetero

Hetero is one of India’s leading generic pharmaceutical companies and the world’s largest producer of anti-retroviral drugs for the treatment of HIV/AIDS. Backed by over 25 years of expertise in the pharmaceutical industry, Hetero’s strategic business areas spread across APIs, Generics, Biosimilars, Custom Pharmaceutical services and Branded Generics. Hetero has 36 state-of-the-art manufacturing facilities strategically located worldwide, audited and approved by stringent regulatory authorities like US FDA, EU, TGA-Australia, MCC-South Africa and others. Our portfolio includes 300 plus products encompassing major therapeutic categories such as HIV/AIDS, Oncology, Cardiovascular, Neurology, Hepatitis, Nephrology, Urology, Diabetes, Ophthalmology, Hepatology and Immunology etc.Hetero has a strong global presence in over 126 countries and focusses on making affordable medicines accessible to patients worldwide. For more information, log on to: www.hetero.com

Advantage products:

Product Name Category Characteristic & Application CDMF status
Oseltamivir Phosphate
I
Dapoxetine HCl
A
Lurasidone HCL
I
Torsemide
I
Zoledronic Acid
I
Topiramate
I
Dapagliflozin Propanediol Monohydrate
I
Sitagliptin Phosphate Monohydrate
I
Prucalopride Succinate
I
Tadalafil
I
Back List
  • Service Hotline 020-3873-0646

    Wechat
    Get the latest news

COMPANY
About us
Milestones
Our value
Awards & qualifications
PIDI Standard
NEWS
Exhibitions & Seminars
Company News
Industry dynamics
PRODUCTS
Partners
Applications
APIs
Packaging
SERVICES